Business
Illumina launches StrataMap Spatial Solution, a powerful end-to-end spatial whole transcriptome research solution
Illumina, Inc. (NASDAQ: ILMN) today announced the launch of the StrataMap Spatial Solution, offering an unmatched breadth of coverage and resolution to redefine what researchers can detect with spatial transcriptomics. StrataMap Spatial, previously called the Illumina Spatial Solution, is an end-to-end sequencing-based research solution to uncover spatial insights. Spatial transcriptomics is already a critical tool in developmental biology, neuroscience, and oncology research. StrataMap Spatial
About this update from Illumina, Inc.
StrataMap Spatial gives researchers access to spatial biology at true single cell resolution for discovery without boundaries Whole-transcriptome profiling across a large tissue capture area can generate 2x more unique genes per sample than probe-based technologies SAN DIEGO, June 8, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced the launch of the StrataMap Spatial Solution, offering an unmatched breadth of coverage and resolution to redefine what researchers can detect with spatial transcriptomics. StrataMap Spatial, previously called the Illumina Spatial Solution, is an end-to-end sequencing-based research solution to uncover spatial insights. Spatial transcriptomics is already a critical tool in developmental biology, neuroscience, and oncology research. StrataMap Spatial expands researchers' ability to map tissue structure, reveal tissue function, track tumor progression, and identify novel drug targets for precision medicine. "Spatial biology offers a new perspective on how our genetic code manifests in our bodies," said Steve Barnard, PhD, chief technology officer of Illumina. "Our customers are already using StrataMap Spatial's unparalleled discovery power to map intricate tissues and study tumor development. This launch pairs our new spatial solution with our tailored bioinformatics pipeline, reinforcing Illumina's commitment to an insight ecosystem where data-at-scale becomes discovery without boundaries." Highest sensitivity spatial technology provides comprehensive transcriptomic insights StrataMap Spatial gives customers a spatial solution with a large, flexible capture area, single-cell resolution, and unbiased whole-transcriptome profiling. Together, these features allow customers to holistically evaluate spatial relationships across cells, regions, and structures, for a more detailed view of tissue architecture and function. StrataMap Spatial's sequencing-based approach detects twice as many genes per sample than alternative, panel-based technologies. The solution goes beyond the coding transcriptome to detect noncoding genes and pseudogenes, uncovering the hidden signals that drive tissue function and disease. StrataMap Spatial is compatible with enrichment techniques, including those researchers use to identify relevant immune response markers like VDJ clonotypes. StrataMap Spatial m...